Optimizing the Value of β-Lactam Antibiotics Through Extended Infusion

Résumé fourni par la source

In the decade since the World Health Organization (WHO) declared antimicrobial resistance (AMR) a global health threat-the so-called postantibiotic era when common infections would be lifethreatening and when routine surgcal procedures, transplantation, and cancer therapy cannot be supported due to lack of effective antimicrobials-great strides have been made to mitigate against this scenario.1 The US government's National Strategy for Combating Antibiotic-Resistant Bacteria spurred substantial cross-sectorial, interagency collaboration.Furthermore, recognizing the interconnectivity between the health of the planet, the environment, humans, and animals, the One Health concept is gaining momentum.1 However, despite efforts from local and international agencies championing for investment to develop new agents, as well as promoting antimicrobial stewardship interventions, enhanced surveillance, and infection control measures, the effect of AMR on the morbidity and mortality of the world's most at-risk populations continue to demand +

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.